These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32224137)

  • 1. Acetylene containing cyclo(L-Tyr-L-Tyr)-analogs as mechanism-based inhibitors of CYP121A1 from Mycobacterium tuberculosis.
    Ortega Ugalde S; Wallraven K; Speer A; Bitter W; Grossmann TN; Commandeur JNM
    Biochem Pharmacol; 2020 Jul; 177():113938. PubMed ID: 32224137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of novel cYY analogues targeting Mycobacterium tuberculosis CYP121A1.
    Kishk SM; McLean KJ; Sood S; Helal MA; Gomaa MS; Salama I; Mostafa SM; de Carvalho LPS; Munro AW; Simons C
    Bioorg Med Chem; 2019 Apr; 27(8):1546-1561. PubMed ID: 30837169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and evaluation against Mycobacterium tuberculosis of azole piperazine derivatives as dicyclotyrosine (cYY) mimics.
    El-Wahab HAAA; Accietto M; Marino LB; McLean KJ; Levy CW; Abdel-Rahman HM; El-Gendy MA; Munro AW; Aboraia AS; Simons C
    Bioorg Med Chem; 2018 Jan; 26(1):161-176. PubMed ID: 29183661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-Function Analysis of the Essential
    Padayachee T; Lamb DC; Nelson DR; Syed K
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-linking of dicyclotyrosine by the cytochrome P450 enzyme CYP121 from
    Dornevil K; Davis I; Fielding AJ; Terrell JR; Ma L; Liu A
    J Biol Chem; 2017 Aug; 292(33):13645-13657. PubMed ID: 28667013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate and reaction specificity of Mycobacterium tuberculosis cytochrome P450 CYP121: insights from biochemical studies and crystal structures.
    Fonvielle M; Le Du MH; Lequin O; Lecoq A; Jacquet M; Thai R; Dubois S; Grach G; Gondry M; Belin P
    J Biol Chem; 2013 Jun; 288(24):17347-59. PubMed ID: 23620594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface hydrophobics mediate functional dimerization of CYP121A1 of Mycobacterium tuberculosis.
    Kumar A; Campomizzi CS; Jay N; Ferguson S; Scheffler EJ; Lioi J; Tu C; Qu J; Simons C; Estrada DF
    Sci Rep; 2021 Jan; 11(1):394. PubMed ID: 33431984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and structural basis of the reaction catalyzed by CYP121, an essential cytochrome P450 in Mycobacterium tuberculosis.
    Belin P; Le Du MH; Fielding A; Lequin O; Jacquet M; Charbonnier JB; Lecoq A; Thai R; Courçon M; Masson C; Dugave C; Genet R; Pernodet JL; Gondry M
    Proc Natl Acad Sci U S A; 2009 May; 106(18):7426-31. PubMed ID: 19416919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Aryl Substituted Pyrazoles as Small Molecule Inhibitors of Cytochrome P450 CYP121A1: Synthesis and Antimycobacterial Evaluation.
    Taban IM; Elshihawy HEAE; Torun B; Zucchini B; Williamson CJ; Altuwairigi D; Ngu AST; McLean KJ; Levy CW; Sood S; Marino LB; Munro AW; de Carvalho LPS; Simons C
    J Med Chem; 2017 Dec; 60(24):10257-10267. PubMed ID: 29185746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of ssDNA aptamers as potent inhibitors of Mycobacterium tuberculosis acetohydroxyacid synthase.
    Baig IA; Moon JY; Lee SC; Ryoo SW; Yoon MY
    Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1338-50. PubMed ID: 25988243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asparagine-85 Stabilizes a Structural Active Site Water Network in CYP121A1 of
    Campomizzi CS; Uttamrao PP; Stallone JJ; Rathinavelan T; Estrada DF
    Biochemistry; 2024 Mar; 63(5):711-722. PubMed ID: 38380587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Research progresses of Mycobacterium tuberculosis cytochrome P450s as a potential drug target].
    Lu Y; Qiao F; You XF; Yang XY
    Yao Xue Xue Bao; 2014 Apr; 49(4):427-34. PubMed ID: 24974457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural biology and biochemistry of cytochrome P450 systems in Mycobacterium tuberculosis.
    McLean KJ; Munro AW
    Drug Metab Rev; 2008; 40(3):427-46. PubMed ID: 18642141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Function, essentiality, and expression of cytochrome P450 enzymes and their cognate redox partners in Mycobacterium tuberculosis: are they drug targets?
    Ortega Ugalde S; Boot M; Commandeur JNM; Jennings P; Bitter W; Vos JC
    Appl Microbiol Biotechnol; 2019 May; 103(9):3597-3614. PubMed ID: 30810776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active Site Aromatic Residues Play a Dual Role in the Substrate Interaction and Protein Structure in Functional Dimers of CYP121A1 of
    Campomizzi CS; Kumar A; Uttamrao PP; Stallone JJ; Ghanatios GE; Rathinavelan T; Estrada DF
    ACS Infect Dis; 2023 Apr; 9(4):827-839. PubMed ID: 36976833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fragment Profiling Approach to Inhibitors of the Orphan M. tuberculosis P450 CYP144A1.
    Kavanagh ME; Chenge J; Zoufir A; McLean KJ; Coyne AG; Bender A; Munro AW; Abell C
    Biochemistry; 2017 Mar; 56(11):1559-1572. PubMed ID: 28169518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential drug targets in the Mycobacterium tuberculosis cytochrome P450 system.
    Ortiz de Montellano PR
    J Inorg Biochem; 2018 Mar; 180():235-245. PubMed ID: 29352597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochromes P450: novel drug targets in the war against multidrug-resistant Mycobacterium tuberculosis.
    Munro AW; McLean KJ; Marshall KR; Warman AJ; Lewis G; Roitel O; Sutcliffe MJ; Kemp CA; Modi S; Scrutton NS; Leys D
    Biochem Soc Trans; 2003 Jun; 31(Pt 3):625-30. PubMed ID: 12773169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-Activity Relationship and Mode-Of-Action Studies Highlight 1-(4-Biphenylylmethyl)-1H-imidazole-Derived Small Molecules as Potent CYP121 Inhibitors.
    Walter I; Adam S; Gentilini MV; Kany AM; Brengel C; Thomann A; Sparwasser T; Köhnke J; Hartmann RW
    ChemMedChem; 2021 Sep; 16(18):2786-2801. PubMed ID: 34010508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.